Rise of Weightloss Drugs to Reduce Airline Fuel Costs

Weightloss medications are poised to profoundly impact the operational expenses of airlines in the United States, potentially leading to savings of hundreds of millions of pounds annually. Analysts from Jefferies, a distinguished investment bank, have noted that a decrease in passenger weight could result in lighter aircraft, thereby lowering fuel consumption.

Airlines have consistently sought methods to minimise the weight of their aircraft. These measures have included removing olives from salads and utilising lighter materials for in-flight magazines. The growing popularity of weightloss treatments, such as Ozempic and Wegovy, is predicted to further assist airlines in this endeavour, as a slimmer society correlates with reduced fuel consumption.

Jefferies reports that major US airlines, including American Airlines, Delta, United, and Southwest, are set to consume around 16 billion gallons of fuel by 2026. Based on an average fuel price of £2.41 per gallon, these airlines could face a combined fuel expenditure nearing £39 billion, which constitutes approximately 19 per cent of their total operating costs. A 10 per cent reduction in the average weight of passengers has the potential to achieve a 2 per cent savings in fuel consumption, resulting in substantial financial benefits.

Recent statistics indicate a decline in the obesity rate among adults in the US, decreasing from approximately 40 per cent in 2022 to about 37 per cent. This shift suggests there are approximately 7.6 million fewer obese adults compared to three years ago. Moreover, the number of US adults reporting the utilisation of GLP-1 drugs for weight management has increased from 5.8 per cent in February 2024 to 12.4 per cent.

As fuel costs typically represent a significant portion of airlines’ operational expenses, the financial relief provided by reduced aircraft weight could be considerable. Various operational adaptations have already been made by airlines, such as carrying less water and employing lighter serving utensils, all aimed at boosting fuel efficiency.

This ongoing trend indicates that advancements in weight management pharmaceuticals, combined with airlines’ efforts to decrease aircraft weight, could yield substantial financial gains for the aviation industry.